Study of Self or Clinic Administration of DepoProvera
Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
Depot medroxyprogesterone acetate (DepoProvera) is an acceptable form of contraception for
many women. However, difficulty in access may cause many women to discontinue use, often
without the use of another effective method of contraception, thereby leaving them vulnerable
to unintended pregnancy. This study will randomly assign women who present for contraceptive
services to two groups: self or clinic administered SC DMPA. The participants will be
followed for one year to compare continuation rates, acceptability, cost effectiveness,
evidence of skin changes, and need for continued support between the two groups.